REBLOZYL
REBLOZYL
Approved
DIN Number
02505541
Drug Class
Human
Market Date
Nov 23, 2020
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505541
AIG Number0162498001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B03XA06 LUSPATERCEPT
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LUSPATERCEPTActive
Strength: 25 MG / VIAL
Monograph: LUSPATERCEPT